Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA

PURPOSE: The purpose of this study was to identify novel plasma biomarkers for distinguishing nasopharyngeal carcinoma (NPC) patients from healthy individuals who have positive Epstein-Barr virus (EBV) viral capsid antigen (VCA-IgA). MATERIALS AND METHODS: One hundred seventy-four plasma cytokines w...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Ning, Lin, Jian-Hua, Xing, Shan, Liu, Dan, Li, Shi-Bing, Lai, Yan-Zhen, Wang, Xue-Ping, Mao, Min-Jie, Zhong, Qian, Zeng, Mu-Sheng, Liu, Wan-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333976/
https://www.ncbi.nlm.nih.gov/pubmed/29807404
http://dx.doi.org/10.4143/crt.2018.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333976/
https://www.ncbi.nlm.nih.gov/pubmed/29807404
http://dx.doi.org/10.4143/crt.2018.070

Ejemplares similares